← All trials
NCT04824144
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2021
- Primary completion
- Nov 30, 2022
- Completion date
- Dec 31, 2022
- First posted
- Apr 1, 2021
- Last posted
- Nov 15, 2021
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bruyere Research InstituteLead sponsor
- University of OttawaCollaborator
- University of TorontoCollaborator
- Foothills Medical CentreCollaborator
- Bruyere Research InstituteReponsible party - principal investigator
- Bruyere Research InstituteOverall official - principal investigator
- Elisabeth Bruyere HospitalCollaborator
- Providence Care HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.